Form D — Thrombolex, Inc.
0001703764-26-000003 · filed 2026-03-12
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $51,105,000
- Total sold
- $32,775,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Thrombolex, Inc.
- CIK
- 1703764
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 4416 Route 27, Suite A
Kingston, NJ 08528 - Phone
- 844-792-6300
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michael J. Cerminaro · Executive OfficerKingston, NJ Find on LinkedIn ↗
-
Marvin Woodall · Executive OfficerKingston, NJ Find on LinkedIn ↗
-
John Cerminaro · Executive OfficerKingston, NJ Find on LinkedIn ↗
-
Paul A. Stewart · DirectorKingston, NJ Find on LinkedIn ↗
-
David Bonita · DirectorKingston, NJ Find on LinkedIn ↗
-
Sam Liang · DirectorKingston, NJ Find on LinkedIn ↗
-
Keegan Harper · DirectorKingston, NJ Find on LinkedIn ↗
-
Clay DeMarcus · DirectorKingston, NJ Find on LinkedIn ↗
View original on SEC EDGAR.